ECB Bancorp, Inc. /MD/ (ECBK) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 209.33%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 209.33% | Share-based compensation / revenue. Period ending 2026-06-30. $1.28M ÷ $611.00K × 100 ≈ 209.33% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 611.00K USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 1.28M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $611.00K | $1.28M | (m) | (m) | (m) | 209.33% | (m) | (m) |
| 2026-03-31 | (m) | $613.00K | $1.22M | (m) | (m) | (m) | 199.67% | (m) | (m) |
| 2025-12-31 | (m) | $598.00K | $1.23M | (m) | (m) | (m) | 206.19% | (m) | (m) |
| 2025-09-30 | (m) | (m) | $434.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | $482.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | $506.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $494.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | $259.00K | (m) | $39.99M | (m) | (m) | (m) | Reported |
| 2024-06-30 | (m) | (m) | $249.00K | (m) | $37.20M | (m) | (m) | (m) | Reported |
| 2024-03-31 | (m) | (m) | $248.00K | (m) | $34.08M | (m) | (m) | (m) | Reported |
| 2023-12-31 | (m) | (m) | $268.00K | (m) | $29.99M | (m) | (m) | (m) | Reported |
| 2023-09-30 | (m) | (m) | $709.00K | (m) | $23.90M | (m) | (m) | (m) | Reported |
| 2023-06-30 | (m) | (m) | $810.00K | (m) | $17.04M | (m) | (m) | (m) | Reported |
| 2023-03-31 | (m) | (m) | $698.00K | (m) | $10.52M | (m) | (m) | (m) | Reported |
| 2022-12-31 | (m) | (m) | $559.00K | (m) | $5.51M | (m) | (m) | (m) | Reported |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $0.00 | (m) | $3.68M | (m) | (m) | (m) | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rhinebeck Bancorp, Inc. (RBKB) | United States | $0.201B | 19.62 |
| SR Bancorp, Inc. (SRBK) | United States | $0.156B | 29.64 |
| Hoyne Bancorp, Inc. (HYNE) | United States | $0.134B | 543.34 |
| Winchester Bancorp, Inc./MD/ (WSBK) | United States | $0.118B | |
| Bogota Financial Corp. (BSBK) | United States | $0.117B | |
| FB Bancorp, Inc. /MD/ (FBLA) | United States | $0.259B | -858.40 |
| First Northwest Bancorp (FNWB) | United States | $0.096B | -7.24 |
| Texas Community Bancshares, Inc. (TCBS) | United States | $0.049B | |
| Marathon Bancorp, Inc. /MD/ (MBBC) | United States | $0.046B | 25.71 |
| FS Bancorp, Inc. (FSBW) | United States | $0.329B | 9.63 |